Network Meta-analysis of Seven Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Outcome Trials Data

被引：1
|
作者：
Alfayez, Osamah
Alkhezi, Omar
Almutairi, Abdulaali R.
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-445-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
445-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effects of glucagon-like peptide-1 receptor agonists on patients with heart failure: a meta-analysis of randomized controlled trials
    Obata, Shota
    Miyamoto, Yoshihisa
    Slipczuk, Leandro
    Takagi, Hisato
    Kuno, Toshiki
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (02) : 132 - 137
  • [42] Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials
    M. Monami
    B. Nreu
    A. Scatena
    S. Giannini
    F. Andreozzi
    G. Sesti
    E. Mannucci
    Journal of Endocrinological Investigation, 2017, 40 : 1251 - 1258
  • [43] Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials
    Monami, M.
    Nreu, B.
    Scatena, A.
    Giannini, S.
    Andreozzi, F.
    Sesti, G.
    Mannucci, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (11) : 1251 - 1258
  • [44] Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials
    Matteo Monami
    Ilaria Dicembrini
    Besmir Nreu
    Francesco Andreozzi
    Giorgio Sesti
    Edoardo Mannucci
    Acta Diabetologica, 2017, 54 : 1101 - 1114
  • [45] Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis
    Lana C. Pinto
    Mariana R. Falcetta
    Dimitris V. Rados
    Cristiane B. Leitão
    Jorge L. Gross
    Scientific Reports, 9
  • [46] Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis
    Pinto, Lana C.
    Falcetta, Mariana R.
    Rados, Dimitris, V
    Leitao, Cristiane B.
    Gross, Jorge L.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [47] Effect of Glucagon-like Peptide-1 Receptor Agonists on All-cause Mortality and Cardiovascular Outcomes: A Meta-analysis
    Peterson, Shaylee C.
    Barry, Arden R.
    CURRENT DIABETES REVIEWS, 2018, 14 (03) : 273 - 279
  • [48] Glucagon-like peptide-1 receptor agonists and cardiovascular events: a meta-analysis of randomized clinical trials (vol 27, pg 57, 2011)
    Monami, M.
    Cremasco, F.
    Lamanna, C.
    Colombi, C.
    Desideri, C. M.
    Iacomelli, I.
    DIABETIC MEDICINE, 2013, 30 (12) : 1512 - 1512
  • [49] Glucagon-Like Peptide-1 Receptor Agonists in Adult Patients With Type 2 Diabetes: Review of Cardiovascular Outcome Trials
    Varin, Elodie M.
    McLean, Brent A.
    Lovshin, Julie A.
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 68 - 77
  • [50] The cardiovascular effects of glucagon-like peptide-1 receptor agonists: a trial sequential analysis of randomized controlled trials
    Wu, S.
    Sun, F.
    Zhang, Y.
    Yang, Z.
    Hong, T.
    Chen, Y.
    Zhan, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (01) : 7 - 13
12345